Subsequent studies have found that miR-130b-3p could target IGF-1, which has been reported about its elevation in fibrotic lung diseases, such as IPF[26,27], coal worker’s lung fibrosis[40], fibroproliferative ARDS[41], as well as bleomycin-induced mouse lung fibrosis[42]. The gene discussed is IGF1; the disease is pulmonary fibrosis.